Underrepresentation of patients with skin of color in clinical trials is an issue in medical research, including in research about dermatological conditions. A study in the January Journal of Drugs in Dermatology looked at the diversity of patients enrolled in melasma clinical trials to determine if there are any disparities in representation. I interviewed author Jared Jagdeo, MD, MS, associat …

Continue reading "JDD Buzz Series | Diversity in Melasma Clinical Trials"